Bigul

Global Longlife Hospital and Research Ltd - 543520 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyGlobal Longlife Hospital and Research Ltd 2CIN NO.L85110GJ2012PLC068700 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 3.64 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Mr Deepak Sharma Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Ms Hetal Thakkar Designation: Chief Financial Officer EmailId: [email protected] Date: 29/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
29-04-2023
Bigul

Global Longlife Hospital and Research Ltd - 543520 - Certificate Under Regulation 40(9) Read With Regulation 40(10) Of The SEBI (LODR) Regulations, 2015

Submission of certificate under Regulation 40(9) read with Regulation 40(10) of the SEBI (LODR) Regulations, 2015
27-04-2023
Bigul

Global Longlife Hospital and Research Ltd - 543520 - Compliance Certificate For The Period Ended March 31, 2023

Compliance Certificate for the period ended March 31, 2023 pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
12-04-2023
Bigul

Global Longlife Hospital and Research Ltd - 543520 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2023
08-04-2023
Bigul

Global Longlife Hospital and Research Ltd - 543520 - Non-Applicability Of Regulation 24A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Annual Secretarial Compliance Report.

Submission of Clarification letter for Non-Applicability of Regulation 24(A) (2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
03-04-2023
Bigul

Global Longlife Hospital and Research Ltd - 543520 - Closure of Trading Window

We would like to inform you that the Trading Window for the dealing in the securities of the Company will be closed for Designated Persons of the Company from Saturday, 01st day of April, 2023 till 48 hours after the declaration of the Audited Financial Results of the Company for the Half-Year and Year ended on March 31, 2023.
31-03-2023
Bigul

Global Longlife Hospital and Research Ltd - 543520 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Rajnjkant Shah
02-03-2023
Bigul

Global Longlife Hospital and Research Ltd - 543520 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Rajnikant Shah
01-03-2023
Bigul

Global Longlife Hospital and Research Ltd - 543520 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2022.
11-01-2023
Bigul

Global Longlife Hospital and Research Ltd - 543520 - Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal

The company has received a notification via email i.e. [email protected] on January 03, 2023 from the 'National Company Law Tribunal' regarding filing of an application by Mr. Rajesh Kashiram Agrawal (a financial creditor of the company) against M/s Global Longlife Hospital and Research Limited at NCLT, Ahmedabad.
03-01-2023
Next Page
Close

Let's Open Free Demat Account